U.S. Luxury Stock News

Wondering whether Euronet Worldwide at US$67.78 is a potential bargain or a value trap? This article walks through the key signals you need to weigh before deciding how it fits in your portfolio. The stock has had a tough run, with the share price down 3.0% over the past week, 9.9% over the last month, 8.5% year to date, and 36.3% over the past year. This adds to a 39.8% decline over three years and 54.0% over five years. Recent headlines around Euronet Worldwide have focused on its position...

Oculis Holding secured a formal Special Protocol Assessment agreement from the U.S. FDA for its pivotal Phase 3 PIONEER-1 trial of Privosegtor in optic neuritis. The SPA confirms that the trial design and analysis are acceptable to support a potential future regulatory submission, assuming the study meets its endpoints. Privosegtor already holds FDA Breakthrough Therapy and EMA PRIME designations, positioning it as a potential neuroprotective therapy in optic neuritis. For investors...

Wondering if Caterpillar at US$872.56 is still offering value after a huge run, or if you are arriving late to the story. The stock has pulled back around 3.3% over the last week, after returns of 9.3% over 30 days and 45.8% year to date, with a 1 year return of 157.5% and substantial multi year gains. Recent coverage has focused on Caterpillar's role as a heavyweight in capital goods and construction equipment, with investors watching how large infrastructure projects and equipment spending...

Investors may be wondering if SentinelOne at around US$17.97 is still offering value after its recent moves, or if the easy win is already gone. The stock has gained 11.8% over the past week and 25.5% over the last month, while the year to date return sits at 22.7% and the 1 year return shows a decline of 7.4%. Recent coverage has focused on how investors are reassessing cybersecurity stocks and what that could mean for growth expectations, while also debating how much risk is already...

Earlier this month, Tenable Holdings announced the general availability of Tenable Hexa AI for its Tenable One Exposure Management Platform and unveiled new Anthropic-powered capabilities to automate and orchestrate cybersecurity workflows across existing security and IT tools. Beyond expanding its AI feature set, Tenable’s move to embed agentic AI and Claude-powered workflows into real-world security operations highlights how it aims to deepen its role in customers’ day-to-day cyber risk...

Earlier in May 2026, CACI International secured a US$113.8 million U.S. Navy contract supporting Military Sealift Command integrated business systems, and previously named former L3Harris executive Christopher Monoski as Executive Vice President, Manufacturing to centralize advanced defense technology production. Together, the long-duration Navy work and new manufacturing leadership underscore CACI’s push into more complex, hardware-enabled national security programs that require scaled,...

In May 2026, MSCI reported strong Q1 results with double-digit organic revenue growth, record asset-based fee levels, and continued momentum across its core index, analytics, and data franchises, while Chairman and CEO Henry A. Fernandez bought more than US$2.2 million of MSCI shares in mid-May. Taken together, the broad-based earnings strength, active use of acquisitions and AI, and fresh insider buying provide investors with additional insight into how MSCI’s leadership is positioning the...

Provident Financial Services (NYSE:PFS) reported strong Q1 earnings with record fee income. The company highlighted robust commercial loan expansion alongside an uptick in nonperforming loans. Management also pointed to higher technology related expenses as a near term pressure point. For investors tracking NYSE:PFS, the fresh Q1 update adds additional detail beyond the share price alone. The stock most recently closed at $22.15, is up 12.2% year to date and 38.3% over the past year, and...

Essex Property Trust, Inc. has affirmed a quarterly dividend of US$2.5900 per share, payable on July 15, 2026, to shareholders of record as of June 30, 2026, with the ex-dividend date also on June 30, 2026. This payout comes shortly after a Q1 update in which Essex highlighted stronger-than-expected core funds from operations and rent growth, alongside reaffirmed full-year guidance and continued share repurchases. With Essex reaffirming guidance and pointing to stronger core funds from...

Bausch + Lomb (BLCO) is in focus after launching PreserVision AREDS3 eye vitamins in the U.S., a new formula that combines established AREDS2 nutrients with an added B vitamin complex for age related macular degeneration. See our latest analysis for Bausch + Lomb. At a share price of US$16.20, recent 90 day share price returns are down 8.22%. However, the 1 year total shareholder return of 44.77% suggests earlier momentum that has cooled in recent months as product launches like PreserVision...

Lumen Technologies (LUMN) is in focus after unveiling NorthLine, a new low latency fiber route linking Seattle and Minneapolis, along with extending deadlines on its ongoing debt exchange offers for Qwest notes. See our latest analysis for Lumen Technologies. Those network and balance sheet moves come after a stronger run in the stock, with a 30 day share price return of 7.38% and a 1 year total shareholder return of 144.36%, suggesting momentum has picked up over the past year. If this kind...

Trane Technologies (NYSE:TT) has launched the BrainBox AI Trane Technologies AI Lab and showroom in Montréal. The new facility is focused on AI driven energy efficiency and sustainability solutions for buildings and cold-chain systems. The launch builds on Trane Technologies' recent acquisition of BrainBox AI and expands its work on autonomous HVAC and transport refrigeration technologies. For investors tracking Trane Technologies at a current share price of $451.69, this move indicates a...

Regencell Bioscience Holdings (RGC) is back in focus after multiple securities class action lawsuits and a disclosed DOJ investigation into trading activities raised fresh questions about market manipulation risk and prior disclosures. See our latest analysis for Regencell Bioscience Holdings. Regencell’s share price has been volatile, with a 1 day share price return of 1.44% and a 90 day share price return that is down 18.14%. At the same time, the year to date share price return of 33.35%...

Recent share performance and valuation snapshot Progress Software (PRGS) has drawn fresh attention after a period of mixed share performance, with the stock closing at $29.21 and sitting on a market value of about $1.22b. Over the past week the stock gained 10.77%, while the past month shows a decline of 6.74% and the past 3 months are down 19.80%. Over 1 year, the total return declined 52.77%, with the 3 year and 5 year total returns down 49.52% and 31.33% respectively. At this level,...

AbbVie (ABBV) is back on investors’ radar after a recent move in its share price, with the stock closing at US$212.30. That shift has sharpened the focus on its current valuation and recent returns. See our latest analysis for AbbVie. Recent trading has been mixed, with a 4.22% 1 month share price return but a 7.42% decline year to date. However, the 1 year total shareholder return of 20.58% and 5 year total shareholder return of 123.26% point to stronger longer term momentum. If AbbVie’s...

In mid-May 2026, Bank of America Corporation announced and completed several fixed-income offerings, issuing multiple series of senior unsecured, callable notes across maturities from 2027 to 2046 with fixed coupons ranging from 4.25% to 6.00% and individual deal sizes up to US$50 million. These transactions coincided with broader scrutiny of the bank’s profitability profile, including an analyst downgrade highlighting pressure on net interest income and structural cost headwinds. Beyond...

If you are wondering whether LiveRamp Holdings at around US$37.73 is still reasonably priced or already running ahead of itself, you are in the right place for a clear valuation check. The stock has recently seen sharp moves, with returns of 32.0% over the last 7 days, 28.1% over the past month, 37.6% year to date, 34.4% over 1 year and a decline of 22.1% over 5 years. Recent news coverage has focused on LiveRamp Holdings as a data connectivity and marketing technology stock that sits in the...

Genpact (G) is back in focus after expanding its alliance with Google Cloud to build AI led finance solutions for CFOs, a move that closely follows its recent first quarter results and updated 2026 guidance. See our latest analysis for Genpact. Genpact’s share price has been under pressure despite these AI and guidance updates, with the stock down about 30% year to date and the 1 year total shareholder return also declining about 25%. This suggests sentiment is still cautious even as...

Earnings surprise puts SM Energy (SM) in focus SM Energy (SM) has moved into the spotlight after its latest earnings report topped analyst expectations, extending a run of positive earnings surprises that has supported stronger sentiment around the stock. See our latest analysis for SM Energy. The latest earnings surprise comes on top of strong recent share price momentum, with SM Energy’s share price return of 29.26% over 30 days, 48.25% over 90 days and 81.97% year to date. Its 5 year total...

Investors may be wondering whether MongoDB at around US$329 per share is still a sensible entry or hold after a strong run, or whether expectations have run too far ahead of reality. Over the short term the stock has risen 8.6% over the past week and 24.6% over the past month, while year to date it is down 17.6% and up 77.9% over the past year. These shifts can influence how the market prices risk and growth potential. These price moves sit against a backdrop of ongoing interest in database...

SEI Investments has launched the SEI High Yield Bond & Alternative Credit ETF (ticker: LEND), its first fixed income ETF, by converting the long-running SIMT High Yield Bond Fund into a more accessible, cost-efficient exchange-traded format. The move brings a three-decade investment track record in high yield and alternative credit into an ETF structure that blends multi-manager exposure with an internally managed CLO sleeve, broadening SEI’s product toolkit for income-focused...

ATRenew (NYSE:RERE) has opened 2026 with Q1 revenue of C¥6.2b and basic EPS of C¥0.56, setting the tone for investors watching how the business is scaling earnings off a larger top line. The company has seen quarterly revenue move from C¥4.7b and EPS of C¥0.18 in Q1 2025 to C¥6.2b and C¥0.56 respectively in Q1 2026. Trailing twelve month EPS reached C¥1.77 on revenue of C¥22.6b, giving investors a clearer view of how profitability is tracking against growth. With net profit margin over the...

CAVA Group (CAVA) reported Q1 2026 results with Q4 2025 revenue at US$275 million and basic EPS of US$0.04, while trailing 12 month revenue stood at about US$1.18 billion with basic EPS of US$0.55 and a net income of US$63.7 million. Over the past year, revenue on a trailing 12 month basis moved from US$963.7 million with basic EPS of US$1.14 to US$1.18 billion with basic EPS of US$0.55. This gives investors a clearer view of how top line expansion has been paired with more modest per share...

Stock performance snapshot D.R. Horton (DHI) has seen mixed share performance recently, with the stock up about 5.2% over the past day and roughly 0.7% across the past week, but down over the past month. Over the past 3 months the stock has also declined, while the year to date return is slightly lower. Even so, the 1 year, 3 year and 5 year total returns remain positive. This provides a longer term reference point alongside the recent pullback. See our latest analysis for D.R. Horton. The...